Clinical Trials Directory

Trials / Completed

CompletedNCT00649116

Fed Study of Metoprolol Tartrate Tablets 100 mg and Lopressor® 100 mg

Single-Dose Food In Vivo Bioequivalence Study of Metoprolol Tartrate Tablets (100 mg; Mylan) and Lopressor® (100 mg; Novartis) in Healthy Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Mylan Pharmaceuticals Inc · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The objective of this study was to investigate the bioequivalence of Mylan's metoprolol tartrate tablets to Novartis's Lopressor® tablets following a single, oral 100 mg (1 x 100 mg) dose administered under fed conditions.

Conditions

Interventions

TypeNameDescription
DRUGMetoprolol Tartrate Tablets 100 mg100mg, single dose fed
DRUGLopressor® Tablets 100 mg100mg, single dose fed

Timeline

Start date
2002-12-01
Primary completion
2002-12-01
Completion
2003-01-01
First posted
2008-04-01
Last updated
2024-04-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00649116. Inclusion in this directory is not an endorsement.